Hyperbaric Oxygen Compared to Pharmaceutical Therapies for Fibromyalgia Syndrome

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

June 1, 2022

Study Completion Date

June 1, 2022

Conditions

FibromyalgiaHyperbaric Oxygen

Interventions

DEVICE

Hyperbaric oxygen therapy (HBOT) treatment

60 HBOT sessions at 2 ATA 100% oxygen

DRUG

Cymbalta / Lyrica treatment

one of the two medications currently licensed for the treatment of FMS in Israel, i.e. Cymbalta and Lyrica.

DEVICE

Crossover Hyperbaric oxygen therapy

60 HBOT sessions at 2 ATA 100% oxygen after crossover

Trial Locations (1)

Assaf-Harofeh Medical Center, Ẕerifin

All Listed Sponsors

lead

Assaf-Harofeh Medical Center

OTHER_GOV

NCT03325959 - Hyperbaric Oxygen Compared to Pharmaceutical Therapies for Fibromyalgia Syndrome | Biotech Hunter | Biotech Hunter